Clinical Trial Update: Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy [EARLY_Phase 1]

View source ↗

Summary

A early-phase (Phase 1) trial of VGT-309, a fluorescent probe for identifying cancerous colorectal lesions during augmented colonoscopy, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• VGT-309

Snippet

Sponsor: Stephan Rogalla | Conditions: Colorectal Cancer | EARLY_Phase 1 | Status: TERMINATED